AzTrials
AzTrials

Mild Obstructive Sleep ApneaPhase 2MTASSANCT06587256

Study to Examine the Effect of Silicone Mouth Tape on Snoring and Mild Sleep Apnea.

A Phase 2 study testing Mouth Tape in people with Mild Obstructive Sleep Apnea and Snoring, run by Johns Hopkins University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record

Search all trials

Trial summary

Snoring is a common problem caused by vibration of tissues in the throat region during sleep. Although snoring is sometimes dismissed as a minor nuisance rather than a medical disorder, several studies indicate that snoring can disrupt sleep quality of the snorer, as well as the snorer's bed partner. Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Mild Obstructive Sleep Apnea, Snoring
What is being tested?
Mouth Tape
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteUnited States
Study dates
1 Mar 2027to Oct 2030
Phase
Phase 2

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patients with a body mass index of 35 kg/m2 with a self-reported history of snoring and a bed partner who can provider answers to about the patients snoring. Patients must have a prior sleep study that shows no sleep apnea, or mild sleep apnea (AHI under 15 events/hr).

Who cannot join

  • Allergy to silicone mouth tape, chronic lung disease, facial hair preventing wearing of the tape
  • Grade 3+ or 4+ tonsils, prior palatal or tongue surgery.
  • Patients may not have any form of chronic or acute hypoventilation.
  • Patients must be able to tolerate breathing through their nose with the mouth tape in place for at least 3 minutes.
  • Patients may not be pregnant

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Mariah Potocki Study Coordinator contact

410-550-2233

mchaney7@jhmi.edu

Athena Mavronis contact

410-550-4588

amvaron1@jhmi.edu

United States1 site, 1 recruiting
  • Johns Hopkins Bayview Medical Center

    Baltimore, Maryland, 21224

    Mariah Potocki, 410-550-2233, mchaney7@jhmi.edu

    Athena Mavronis, 410-550-4588, amavron1@jhmi.edi

    Recruiting

Other trials in United States

About this study

Official title: Mouth Tape for Snoring and Sleep Apnea (MTASSA)

Snoring is a common problem caused by vibration of tissues in the throat region during sleep. Although snoring is sometimes dismissed as a minor nuisance rather than a medical disorder, several studies indicate that snoring can disrupt sleep quality of the snorer, as well as the snorer's bed partner. Snoring also might lead to problems such as dry mouth, bad breath, dental problems, and even cardiovascular disease. Current treatments for snoring include lifestyle modifications such as weight loss, side-sleeping, and avoidance of evening alcohol intake. In some cases, invasive surgeries, dental devices, or even CPAP are recommended for snoring. These interventions have mixed effectiveness and may be difficult to use.

It may be possible to treat snoring by fostering nasal breathing, while avoiding mouth-breathing during sleep. Breathing through the mouth reduces the airway diameter and contributes to snoring. Several studies show that nasal breathing can reduce snoring volume and improve airflow. Recent studies have shown that covering the mouth during sleep with adhesive patches or tape can improve snoring volume without adverse effects. However, these studies were performed in a small number of patients and did not fully measure the impact of the intervention on sleep quality, sleep architecture, or the experience of the bed partner, who is often the overlooked "victim" of the snoring. In this interventional study, the investigators will examine the safety and efficacy of mouth tape for snoring, focusing on subjective and objective snoring/breathing metrics of both the snorer and bed partner.

Snoring is sometimes also a sign of obstructive sleep apnea (OSA). If OSA is ruled out with a sleep study, patients are considered to have "simple" snoring. When OSA is mild (apnea hypopnea index 15), treatments can include the same interventions as snoring (e.g. weight loss, avoidance of alcohol, side-sleeping) or can be more aggressively treated with devices such as continuous positive airway pressure (CPAP). CPAP may be challenging to use, expensive, and associated with side effects such as mouth dryness and skin irritation. Alternative, inexpensive, and well-tolerated interventions are needed for mild OSA. For this reason, the investigators include patients with snoring and mild OSA in this study.

Read the detailed description

Snoring affects hundreds of millions of people worldwide and describes vibration of airway tissues including the palate, tongue, tonsils, and epiglottis. In a random sample of middle-aged adults, habitual snoring was reported by 45%. Snoring decreases the sleep quality of the snoring individual and the snorer's bed partner, causes social stigma, and may lead bed partners to sleep in separate rooms. Snoring may also be a manifestation of obstructive sleep apnea (OSA), in which the upper airway collapses partially or fully, leading to episodic pauses in breathing (apneas) or shallow breathing (hypopneas). While many physicians and patients recognize health risks of OSA, snoring is often dismissed as "benign" or "simple", but this is a misnomer. Heavy snoring per se can contribute to unrefreshing sleep and daytime fatigue. In study of 400 adult women who underwent polysomnography, snoring was associated with daytime sleepiness, even after adjustment for the presence of OSA. Data from a home sleep apnea testing device equipped with a snoring microphone found that loud sustained snoring predicted daytime sleepiness better than intermittent bursts of sound characteristic of OSA. Other studies suggest that snoring may increase risks of carotid atherosclerosis which could increase the chances of a stroke. A study of surgery for simple snoring reported improvements in marital life after surgery illustrating the impact of snoring and its resolution on sleep quality and relational health. Hence, snoring is a highly prevalent problem that impairs the sleep quality of snorers and the snorer's bed partner.

Current approaches to snoring include weight loss, avoidance of tobacco and alcohol, lateral sleep, nasal decongestants or steroids, nasal dilator adhesive devices, surgeries, or devices (such as CPAP or mandibular advancement devices). Most of these therapies are recommended on the basis of anecdotes and small studies. Insurance generally does not cover CPAP or oral appliances for simple snoring. Despite the nearly ubiquitous nature of snoring, there is no well-researched standard of care.

A large proportion of air enters and exits the nose during typical awake breathing. During sleep some people breathe more orally, which predisposes to snoring and OSA by increasing upper airway resistance and decreasing retro-glossal and retro-palatal area. Under sedation, mouth opening caused a significant increase in the upper airway critical pressure indicating a greater likelihood of airway obstruction compared to mouth closure. Using an oronasal ("full face") mask with a partition installed between the nose and mouth, closure of the nasal port caused severe OSA, which resolved after closing only the mouth port to force nasal breathing, or opening both ports to allow spontaneous breathing. CPAP applied via an oronasal mask is less effective than CPAP applied via a nasal mask. In recent studies, mouth occlusion with a plastic barrier device or silicone tape dramatically reduced snoring volume, and lowered the apnea hypopnea index (AHI) in patients with mild OSA or simple snoring. Mouth closure with a barrier device also improved the performance of an oral appliance for treatment of OSA. These studies demonstrate that mouth breathing predisposes to snoring and OSA, and that diverting breathing through the nose can reduce snoring. However, these studies are limited by small sample size, a homogenous population (Asian men with normal BMI), short study duration, and lack of input from the bed partner.

This project investigates the efficacy of mouth tape in two common clinical scenarios. First, the scenario of a patient with simple snoring after OSA has been ruled out. These patients are typically prescribed lifestyle modification (weight loss, avoidance of supine sleep, tobacco and alcohol) or non-prescription remedies such as nasal dilator strips or decongestant sprays. The second scenario is a patient presenting with snoring and few other symptoms who is found to have mild OSA (apnea hypopnea index, AHI 15). While the treatment for mildly symptomatic mild OSA is debated, the first line therapy is typically CPAP or lifestyle modification. Adherence to CPAP is notoriously challenging. Even among patients who use CPAP chronically, there are frequent side effects such as skin abrasions. Mouth tape might be another treatment option for these patients.

The investigators justify the combined inclusion of snoring patients and those with mild OSA in this study for several reasons. First, overlap in physiology: the same individual may be diagnosed with simple snoring on one night and mild OSA on another, as snoring and OSA are caused by inspiratory flow limitation, which may manifest as night-to-night variability of AHI on sleep studies. Second, overlap in evidence-based management: patients with mild OSA are often managed similarly to simple snorers, since the necessity of CPAP (or other therapies) for mild OSA is controversial. Third, overlap in clinical need: there is significant demand for alternative effective and well-tolerated treatments for both conditions.

In the clinical setting of simple snoring or mild OSA, the investigators will offer patients the option of mouth tape during sleep. A small piece of silicone mouth tape is placed vertically over the lips without fully occluding the mouth, which the investigators hypothesize will lower snoring volume and improve sleep quality for the snorer and bed partner. Patients will be carefully screened who tolerate nasal breathing and have no other complicating cardiopulmonary disease. In consented patients the investigators will measure the safety and tolerability of mouth tape, and the impact of mouth tape on sleep and snoring as perceived by the patient and bed partner after 3 months.

Interestingly, mouth taping has become a viral social media trend with the hashtag mouth taping (#mouthtaping) on Tiktok reaching 160 million views as of 1/5/2024. Many of these posts make bold claims about improved sleep quality, improved sinuses, and even lower blood pressure with mouth taping. The medical community has been slow and uncertain in its response to this phenomenon, illustrating the need for more rigorous research.

Being tested
Mouth Tape
Keywords
sleep apnea, snoring, mouth tape
Medical subject headings
Snoring, Sleep Apnea Syndromes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mouth TapeDevice

    A single piece of silicone tape placed vertically over the lips. When positioned properly the participant can still inhale/exhale and cough around the tape if needed, but will tend to keep mouth closed otherwise.

Study groups in NCT06587256
Study groupRoleWhat they receive
Simple snorers or Mild Sleep ApneaExperimentalPatients with snoring and a prior sleep study showing an AHI < 15.
Receives: Device: Mouth Tape

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Snoring / Sleep Survey (SSS)

    The patient will be asked about perceived snoring and sleep quality (score range 0-25, best=0, worst =25)

    Measured: Baseline and 3 months

Secondary outcomes (7)
  1. Adherence and tolerance questionnaire

    Asks about ease of use and any intolerances (score range 0-100, hard = 0, 100=easy).

    Measured: 3 months

  2. Sleep apnea severity (WatchPAT)

    The investigators will use a home sleep apnea test. Sleep apnea severity will be scored based on peripheral arterial tonometry (PAT)-signal derived apnea hypopnea index (pAHI).

    Measured: Baseline and 3 months

  3. Snoring intensity (WatchPAT)

    The investigators will use a home sleep apnea test. Snoring intensity be me measured using vibration assessment to derive estimate decibels (dB).

    Measured: Baseline and 3 months

  4. PROMIS Sleep Related Disturbance (SD) Short Form 8A (PROMIS-SD-8A)

    PROMIS-SD 8a questionnaire asks about perceived sleep quality (score range 0 - 40, 0=very poor, 40=very good)

    Measured: Baseline, 2 weeks, and 3 months

  5. PROMIS Sleep Related Impairment (SRI) Short Form 8A (PROMIS-SRI-8A)

    PROMIS-SRI 8a questionnaire asks about sleep and its impact on daytime function (score range 0 - 40, 0=very impaired, 40=not at all impaired)

    Measured: 2 weeks

  6. Snoring / Sleep Survey (SSS) Bed Partner

    The bed partner will be asked about the participants snoring, and the bed partner's own sleep quality (score range 0-25, best=0, worst =25).

    Measured: Baseline, 2 weeks, and 3 months

  7. Snoring / Sleep Survey (SSS) Patient

    The patient will be asked about snoring and sleep quality (score range 0-25, best=0, worst =25).

    Measured: 2 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Sep 2024
  2. Study start1 Mar 2027 (estimated)
  3. Primary completionOct 2030 (estimated)
  4. Study completionOct 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
This is a single-arm, open-label, non-randomized interventional clinical trial comparing each participant's baseline snoring or sleep apnea level to the participant's 3-month snoring or sleep apnea while using mouth tape during sleep.
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06587256
Sponsor's protocol ID
IRB00425791
Acronym
MTASSA
Status last verified
Jun 2026
First submitted
5 Sep 2024
Last updated
23 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: If requested, a de-identified data set including only participant age, sex, weight, height, questionnaire, and sleep study data will be provided.

Publications

  • Lee YC, Lu CT, Cheng WN, Li HY. The Impact of Mouth-Taping in Mouth-Breathers with Mild Obstructive Sleep Apnea: A Preliminary Study. Healthcare (Basel). 2022 Sep 13;10(9):1755. doi: 10.3390/healthcare10091755.

    PubMed 36141367
  • Huang TW, Young TH. Novel porous oral patches for patients with mild obstructive sleep apnea and mouth breathing: a pilot study. Otolaryngol Head Neck Surg. 2015 Feb;152(2):369-73. doi: 10.1177/0194599814559383. Epub 2014 Dec 1.

    PubMed 25450408

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in